Reminder:July 15-16 Meeting of the Tobacco Products Scientific Advisory Committee Meeting Announcement

July 15-16 Meeting of the Tobacco Products Scientific Advisory Committee Meeting Announcement
Date
July 15, 2010
& July 16, 2010

Time
8:30 a.m. – 5:00 p.m.
8:00 a.m. – 5:00 p.m.

Location
Gaithersburg Marriott Washingtonian Center
9751 Washingtonian Boulevard
Gaithersburg, Maryland
Hotel phone number is 301-590-0044.

Agenda

Guidance Labeling “Light” and Related Products

See the attachment

FDA labeling light

Attached Files:

July 7 and 8 Tobacco Product Constituents Subcommittee of the Tobacco

This notice announces a forthcoming meeting of a public advisory committee of
the Food and Drug Administration (FDA). The meeting will be open to the public.

Name of Committee: Tobacco Product Constituents Subcommittee of the Tobacco

Products Scientific Advisory Committee.

General Function of the Committee: To provide advice and recommendations to the
agency on FDA’s regulatory issues.

Date and Time: The meeting will be held on July 7, 2010, from 8:30 a.m. to 5
p.m. and on July 8, 2010, from 8 a.m. to 5 p.m.

See announcement 

 FDASubC2

Attached Files:

Star Scientific, Rock Creek Pharmaceuticals Present at FDA Advisory Subcommittee Meeting

Star Scientific, Inc. (Nasdaq: CIGX) issued the following statement today from Paul L. Perito, the company’s Chairman and President:

Curtis Wright, MD, MPH, Senior Vice President and Ryan Lanier, Ph.D., of Rock Creek Pharmaceuticals, made a presentation on tobacco toxins on Tuesday June 8 to the FDA Tobacco Products Scientific Advisory Subcommittee on Tobacco Product Constituents. This subcommittee of the agency’s Tobacco Products Scientific Advisory Committee (TPSAC) was formed to assist with the FDA’s congressional mandate to publish a list of harmful constituents found in tobacco products, and the levels found in each product, within two years after passage of the June 2009 Family Smoking Prevention and Tobacco Control Act.

Ethics group wants FDA to drop two tobacco advisory panel members

By Julian Pecquet – 06/07/10 12:33 PM ET

The good government group Citizens for Responsibility and Ethics in Washington (CREW) wants the Food and Drug Administration to drop two members of its advisory panel on tobacco products for what it calls “clear financial conflicts of interests.”

The group says Neal Benowitz and Jack Henningfield have received money from companies that market smoking-cessation products and acted as expert witnesses paid by plaintiffs to testify against tobacco companies.